Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Terveystalo Oyj (TTALO.HE)
EUR7.03
-0.56 (-7.38%)
FI HEL Healthcare Medical - Care Facilities
Address
Jaakonkatu 3 A 100
Helsinki, FI
Helsinki, FI
CEO
Ville Iho
Website
terveystalo.com
IPO
2017-10-11
ISIN FI4000252127
Also trades on
NASDAQ Helsinki · TTALO.HE (EUR)
Other OTC · TTALF (USD)
Description
Terveystalo Oyj, based in Helsinki, Finland, stands as a leading provider of healthcare services, with a strong focus on occupational health for businesses across the country. Its extensive service portfolio covers general practitioner consultations, specialized medical care, diagnostic procedures, outpatient and day surgery, and a full spectrum of dental and oral health services. The company further extends its offerings to include laboratory and imaging capabilities, wellbeing programs, child welfare services, and various healthcare outsourcing and staffing solutions. Terveystalo also provides modern digital healthcare platforms and engages in clinical research. Serving a diverse clientele, its customers range from private individuals and corporate entities to insurance companies and the public sector. The company maintains a substantial physical presence, operating 360 clinics throughout Finland, which include 18 hospital units, 38 dental clinics, and 73 Rela hierojat massage therapy units. Terveystalo Oyj was established in 2001.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR7.03
-0.56 (-7.38%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
199.6K
Beta
0.38
Float Shares
79.40M
Free Float %
62.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.97% | +0.49% | +4.23% | -12.77% | -13.33% | -15.58% | -33.47% | +0.87% | -31.22% | -18.70% | -18.70% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
7.03
DCF (Unlevered)
115.47
+1,542.5%
DCF (Levered)
69.43
+887.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
67% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
1.67
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-4.6% Q1'26: -11.2% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+28.1% ★ Q1'26: -46.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+11.5% Q1'26: -3.9% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+10.8% Q1'26: +8.8% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+8.8% ★ Q1'26: +8.1% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.2% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×3.15× Q1'26: 2.96× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
689.50M
est: 698.61M (-1.3%)
|
744.70M
est: 745.65M (-0.1%)
|
1.03B
est: 1.03B (-0.2%)
|
986.40M
est: 984.69M (+0.2%)
|
1.15B
est: 1.14B (+1.3%)
|
1.26B
est: 1.26B (+0.1%)
|
1.29B
est: 1.31B (-2.1%)
|
1.34B
est: 1.35B (-0.5%)
|
1.28B
est: 1.29B (-0.9%)
|
1.23B
1.22B – 1.26B
-4.4% YoY
|
1.25B
1.20B – 1.32B
+1.3% YoY
|
1.30B
1.28B – 1.31B
+3.9% YoY
|
1.30B
1.27B – 1.36B
+0.4% YoY
|
| EBITDA |
67.50M
est: 95.37M (-29.2%)
|
115.90M
est: 101.79M (+13.9%)
|
170.60M
est: 141.00M (+21.0%)
|
157.90M
est: 134.42M (+17.5%)
|
201.40M
est: 155.59M (+29.4%)
|
144.40M
est: 171.66M (-15.9%)
|
91.50M
est: 279.34M (-67.2%)
|
217.40M
est: 286.32M (-24.1%)
|
233.50M
est: 274.40M (-14.9%)
|
262.24M
258.55M – 268.82M
-4.4% YoY
|
265.64M
255.87M – 281.43M
+1.3% YoY
|
276.03M
272.70M – 279.37M
+3.9% YoY
|
277.23M
270.12M – 289.05M
+0.4% YoY
|
| EBIT |
28.30M
est: 37.82M (-25.2%)
|
74.90M
est: 40.37M (+85.5%)
|
81.20M
est: 55.92M (+45.2%)
|
66.70M
est: 53.31M (+25.1%)
|
110.90M
est: 61.71M (+79.7%)
|
40.70M
est: 68.08M (-40.2%)
|
-15.40M
est: 188.53M (-108.2%)
|
115.30M
est: 193.25M (-40.3%)
|
137.60M
est: 185.20M (-25.7%)
|
176.99M
174.50M – 181.43M
-4.4% YoY
|
179.28M
172.69M – 189.95M
+1.3% YoY
|
186.30M
184.05M – 188.55M
+3.9% YoY
|
187.11M
182.31M – 195.08M
+0.4% YoY
|
| Net Income |
7.20M
est: 37.09M (-80.6%)
|
68.70M
est: 58.36M (+17.7%)
|
54.10M
est: 59.42M (-9.0%)
|
45.80M
est: 46.33M (-1.1%)
|
80.50M
est: 82.64M (-2.6%)
|
24.40M
est: 65.61M (-62.8%)
|
-42.20M
est: -22.90M (-84.3%)
|
71.70M
est: 89.40M (-19.8%)
|
92.60M
est: 108.47M (-14.6%)
|
93.91M
88.16M – 99.66M
-13.4% YoY
|
102.95M
95.69M – 112.73M
+9.6% YoY
|
112.85M
102.05M – 122.71M
+9.6% YoY
|
114.45M
110.64M – 120.79M
+1.4% YoY
|
| SGA |
8.90M
est: 4.58M (+94.3%)
|
7.10M
est: 4.89M (+45.2%)
|
7.20M
est: 6.77M (+6.3%)
|
4.60M
est: 6.46M (-28.8%)
|
7.30M
est: 7.47M (-2.3%)
|
8.50M
est: 8.24M (+3.1%)
|
8.70M
est: 34.52M (-74.8%)
|
11.10M
est: 35.38M (-68.6%)
|
132.10M
est: 33.91M (+289.6%)
|
32.41M
31.95M – 33.22M
-4.4% YoY
|
32.83M
31.62M – 34.78M
+1.3% YoY
|
34.11M
33.70M – 34.52M
+3.9% YoY
|
34.26M
33.38M – 35.72M
+0.4% YoY
|
| EPS |
0.06
est: 0.29 (-79.5%)
|
0.54
est: 0.46 (+17.1%)
|
0.43
est: 0.47 (-8.4%)
|
0.36
est: 0.37 (-1.6%)
|
0.63
est: 0.65 (-3.5%)
|
0.19
est: 0.52 (-63.3%)
|
-0.33
est: -0.18 (-82.4%)
|
0.57
est: 0.71 (-19.9%)
|
0.73
est: 0.85 (-13.7%)
|
0.74
0.70 – 0.79
-12.8% YoY
|
0.84
0.75 – 0.89
+14.5% YoY
|
0.91
0.80 – 0.97
+7.9% YoY
|
0.90
0.87 – 0.95
-1.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
110.50M
OE per share TTM
0.85
Owner's Yield
10.73%
Maintenance CapEx ratio
91.36%
Maint CapEx / Avg PPE
22.3%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 39 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.41% | 378.0K | 0.38% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.41% | 378.0K | 0.38% |
| 3 | WisdomTree Europe Equity Income UCITS ETF Acc EEIA.L | 0.15% | 353.2K | 0.29% |
| 4 | WisdomTree Europe Equity Income UCITS ETF WTEE.DE | 0.15% | 353.2K | 0.29% |
| 5 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.11% | 475.8K | 0.48% |
| 6 | WisdomTree International SmallCap Dividend Fund DLS | 0.11% | 1.14M | 0.58% |
| 7 | WisdomTree International High Dividend Fund DTH | 0.05% | 288.8K | 0.58% |
| 8 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.04% | 247.5K | 0.41% |
| 9 | Schwab Fundamental International Small Company Index ETF FNDC | 0.03% | 911.9K | 0.39% |
| 10 | Schwab International Small-Cap Equity ETF SCHC | 0.03% | 1.44M | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
15.6K
Shares Outstanding
126.81M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ville Iho | President & Chief Executive Officer | 1M | male |
| Erika Aallonvuori | Head of Procurement, Premises & Technology | — | — |
| Henri Maenalanen | Executive Vice President of Portfolio Businesses | — | male |
| Hilppa Rautpalo | Senior Vice President of People & Careers | — | female |
| Ilari Richardt | Senior Vice President of Digital Services | — | — |
| Juuso Pajunen | Chief Financial Officer | — | male |
| Elina Saviharju | Senior Vice President of Legal | — | female |
| Niki Kotilainen | Senior Vice President of Operations & Healthcare Services | — | male |
| Petra Grasbeck | Senior Vice President of Communications & Public Affairs | — | female |
| Riina-Riitta Helminen | Chf Ad Med Offr for Reg, Auth Matters, Patient & MedSafety and Dir. of Fokus-unitforGastroenterology | — | — |
| Veera Siivonen | Senior Vice President of Digital Care | — | female |
| Kati Kaksonen | Vice President of Investor Relations, Sustainability & CR | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TTALO.HE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
